Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Acer Therapeutics Inc market cap is $16.15M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Acer Therapeutics Inc 52 week high is $4.56 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Acer Therapeutics Inc 52 week low is $0.5515 as of November 22, 2026.
Acer Therapeutics Inc stock price today is $0.6601.
Acer Therapeutics Inc stock price yesterday was $0.8045.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Acer Therapeutics Inc's P/E ratio is -0.34.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Acer Therapeutics Inc P/B ratio is -0.4857.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Acer Therapeutics Inc 50-day moving average is $0.8149.